Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antiaging Quantum Living Inc AAQL

Antiaging Quantum Living Inc. is an investment holding company. It focuses on Website development, maintenance and online business advertisement. Its primary business operations are conducted through its subsidiaries AAQL Inc., AAQL HK Limited, Antiaging Doctor Hangzhou Holding LTD (Dao Ling Doctor Hangzhou), Dao Ling Doctor (Zhejiang) Health Management Limited (Dao Ling Doctor Zhejiang), and Dao Ling Doctor (Huzhou) Health Management Limited (Dao Ling Doctor Huzhou). Dao Ling Doctor Hangzhou provides development, operation, and management services to domestic e-commerce platform companies, offering personalized marketing plans, promotional strategies, and charging brand usage fees for the Dao Ling Doctor brand. Dao Ling Doctor Zhejiang provides professional technical development and maintenance services to distributors of the Dao Ling Doctor brand and collects technical service fees. Dao Ling Doctor Huzhou provides health consulting services, big data services, and other services.


OTCPK:AAQL - Post by User

Post by JJSNYCon Sep 21, 2011 10:36am
526 Views
Post# 19065755

Achillion Pharmaceuticals, Inc. (ACHN) has a trada

Achillion Pharmaceuticals, Inc. (ACHN) has a tradaAchillion Pharmaceuticals, Inc. (ACHN) has a tradable event at the end of the fourth quarter 2011, phase IIa results for their lead drug candidate, ACHN-1625. An information package is available at BiotechnologyEvents.com. It includes opinion and detailed trade strategies as well as an overview including data and other valuable information.https://www.biotechnologyevents.com/node/3844
Bullboard Posts